Humacyte Inc

-0.48 (-3.62%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.32B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.31 Million
Adjusted EPS-$0.21
See more estimates
10-Day MAN/A
50-Day MAN/A
200-Day MAN/A
See more pivots

Humacyte Inc Stock, NASDAQ:HUMA

2525 East North Carolina Highway 54, Durham, North Carolina 27713
United States of America
Phone: +1.919.313.9633
Number of Employees:


Humacyte, Inc. engages in the manufacture of human acellular matrix products for vascular and non-vascular applications. It offers its products to the cardiovascular, cosmetic, soft tissue reconstruction, neurosurgical, and orthopedic markets. The company was founded by Laura E. Niklason and Juliana L. Blum in October 13, 2004 and is headquartered in Durham, NC.